Dr. Leonard R. Borrmann
Chief Executive Officer
Dr. Leonard R. Borrmann brings a wealth of product development, clinical, and regulatory expertise to Centricity Vision leading R&D initiatives for the company. Dr. Borrmann joined Johnson & Johnson in 2017 with the acquisition of Abbott Medical Optics where he was the Divisional Vice President of Research and Development and retired from J&J as Global Head of External Innovation in 2020. Prior to joining Abbott, Dr. Borrmann held positions of increasing responsibility in R&D, including Executive Vice President R&D with Advanced Medical Optics (acquired by Abbott in 2009). During his 13 years with AMO, Dr. Borrmann led the development and launch of more than 30 new products for AMO’s cataract, refractive and corneal businesses. Prior to joining AMO, Dr. Borrmann was CEO and director for a series of venture-backed biotech companies and had a 15-year career at Allergan Pharmaceuticals Inc., where he held positions of increasing responsibility in Clinical Research, Marketing and Business Development, including Vice President of Business Development.
Dr. Borrmann earned his bachelor’s degree in Psychobiology and Doctor of Pharmacy degree from University of Southern California.